AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 50 filers reported holding AXOVANT GENE THERAPIES LTD in Q3 2019. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,327,000 | -33.9% | 1,152,998 | -59.7% | 0.52% | -31.0% |
| Q2 2020 | $8,060,000 | +12.7% | 2,857,998 | -2.5% | 0.76% | -15.3% |
| Q1 2020 | $7,152,000 | +250.4% | 2,931,018 | +635.4% | 0.90% | +432.7% |
| Q4 2019 | $2,041,000 | -52.7% | 398,541 | -40.4% | 0.17% | -74.8% |
| Q3 2019 | $4,319,000 | +3.7% | 668,541 | 0.0% | 0.67% | +17.0% |
| Q2 2019 | $4,165,000 | – | 668,541 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|